China CRO Company,Preclinical research services

encnjpkr

News

Press Events

Location:Home > News Center > Press Events

  • 07
    28

    2015

    New Study Data Could Lead to Reversal of Aging Process

    There are many among us who believe that time is a predator, patiently waiting for our bodies to age and yield toward its inevitable fate. However, there are few within the sciences that look at the aging process through a different lens—viewing it as a disease, one that can be treated, slowed, and possibly even reversed.

  • 07
    28

    2015

    Blood Holds Clues to Breast Cancer Risk

    Breast cancer is the deadliest cancer for women worldwide. More than 508,000 women are estimated to have died in 2011, with nearly 1.7 million new cases diagnosed the following year (World Health Organization).

  • 07
    27

    2015

    3SBio Acquires Zhejiang Wansheng Pharmaceutical for $85M

    3SBio said it has acquired Zhejiang Wansheng Pharmaceutical for RMB 528 million ($85 million), less than a month after completing the largest IPO of the first half of 2015.

  • 07
    27

    2015

    Biopharms Up Spending by $300 Million on Bioprocess Innovations

    Innovation to improve bioprocessing efficiency is in high demand and the global biopharma industry is increasing their development spending by $300 million in 2015, according to the 12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production from BioPlan Associates.

  • 07
    24

    2015

    Flu Vaccine Becomes Universal

    While many of us are spending the last half of the summer deciding where the nicest beaches are and who makes the best island cocktails, infectious disease scientists are looking ahead toward the next inevitable outbreak of the flu.  Influenza hunters travel to hot zones that have long been the traditional breeding grounds and launching points for global seasonal pandemics. This is an important part of creating seasonal flu vaccines, which protect against only a few specific strains that researchers predict will be the most common for the upcoming year.